Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Genta starts phase-2 trial of oncology product Tesetaxal
Genta starts phase-2 trial of oncology product Tesetaxal
Genta starts phase-2 trial of oncology product Tesetaxal
Submitted by
admin
on February 27, 2010 - 1:17pm
Source:
Pharmabiz
News Tags:
Genta
Tesetaxel
cancer
tubulin inhibitor
Headline:
Genta starts phase-2 trial of oncology product Tesetaxal
Do Not Allow Advertisers to Use My Personal information
